Literature DB >> 2789200

Determination of E-rosette-forming lymphocytes in aged subjects with Taichiquan exercise.

X S Sun1, Y Xu, Y J Xia.   

Abstract

T-lymphocytes were determined by rosette formation with sheep erythrocytes in the peripheral blood obtained from 30 healthy aged subjects who were practicing Taichiquan (88 style) exercise and 30 age-matched normal aged who served as a control group. At rest the total number of T-lymphocytes and the number of active T-lymphocytes were increased significantly in the exercise group compared with the controls. Immediately after a bout of Taichiquan exercise, a marked increase of active T-lymphocytes occurred. In conclusion, the results indicate that frequent Taichiquan exercise causes an increase of T-lymphocytes in the blood.

Entities:  

Mesh:

Year:  1989        PMID: 2789200

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  5 in total

Review 1.  A comprehensive review of health benefits of qigong and tai chi.

Authors:  Roger Jahnke; Linda Larkey; Carol Rogers; Jennifer Etnier; Fang Lin
Journal:  Am J Health Promot       Date:  2010 Jul-Aug

2.  Regular tai chi chuan exercise enhances functional mobility and CD4CD25 regulatory T cells.

Authors:  S-H Yeh; H Chuang; L-W Lin; C-Y Hsiao; H L Eng
Journal:  Br J Sports Med       Date:  2006-03       Impact factor: 13.800

Review 3.  Tai Chi Chuan: an ancient wisdom on exercise and health promotion.

Authors:  Ching Lan; Jin-Shin Lai; Ssu-Yuan Chen
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

4.  Mind-Body, Ki (Qi) and the Skin: Commentary on Irwin's 'Shingles Immunity and Health Functioning in the Elderly: Tai Chi Chih as a Behavioral Treatment'

Authors:  Hiromi Kobayashi; Masamitsu Ishii
Journal:  Evid Based Complement Alternat Med       Date:  2005-03       Impact factor: 2.629

5.  A randomized controlled trial of tai chi for tension headaches.

Authors:  Ryan B Abbott; Ka-Kit Hui; Ron D Hays; Ming-Dong Li; Timothy Pan
Journal:  Evid Based Complement Alternat Med       Date:  2006-08-12       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.